BG102229A - Антагонисти на ендотелинови рецептори - Google Patents

Антагонисти на ендотелинови рецептори

Info

Publication number
BG102229A
BG102229A BG102229A BG10222998A BG102229A BG 102229 A BG102229 A BG 102229A BG 102229 A BG102229 A BG 102229A BG 10222998 A BG10222998 A BG 10222998A BG 102229 A BG102229 A BG 102229A
Authority
BG
Bulgaria
Prior art keywords
receptor antagonists
endothelium receptor
endothelium
antagonistsand
andtriazoles
Prior art date
Application number
BG102229A
Other languages
English (en)
Inventor
Juan Luengo
John Elliott
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of BG102229A publication Critical patent/BG102229A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Изобретението се отнася до нови пироли, пиразоли и триазоли, до фармацевтични състави, съдържащи тези съединения, до използването им като антагонистина ендотелинови рецептори и до методи за тяхното получаване.
BG102229A 1995-08-02 1998-02-02 Антагонисти на ендотелинови рецептори BG102229A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US179295P 1995-08-02 1995-08-02
US1098296P 1996-02-01 1996-02-01
PCT/US1996/012581 WO1997004772A1 (en) 1995-08-02 1996-08-02 Endothelin receptor antagonists

Publications (1)

Publication Number Publication Date
BG102229A true BG102229A (bg) 1998-09-30

Family

ID=26669471

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102229A BG102229A (bg) 1995-08-02 1998-02-02 Антагонисти на ендотелинови рецептори

Country Status (25)

Country Link
US (5) US5969151A (bg)
EP (2) EP0843551B1 (bg)
JP (2) JP2001517195A (bg)
KR (1) KR19990036032A (bg)
CN (1) CN1196680A (bg)
AP (1) AP9801182A0 (bg)
AT (1) ATE341324T1 (bg)
AU (2) AU717172B2 (bg)
BG (1) BG102229A (bg)
BR (1) BR9609914A (bg)
CA (2) CA2228296A1 (bg)
CZ (1) CZ30498A3 (bg)
DE (2) DE69636597T2 (bg)
EA (1) EA000952B1 (bg)
ES (2) ES2273350T3 (bg)
HU (1) HU220776B1 (bg)
MX (1) MX9800975A (bg)
NO (1) NO980422L (bg)
NZ (1) NZ315846A (bg)
OA (1) OA10755A (bg)
PL (1) PL184272B1 (bg)
RO (1) RO115802B1 (bg)
SK (1) SK282584B6 (bg)
TR (1) TR199800152T1 (bg)
WO (2) WO1997004772A1 (bg)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5021171A1 (es) * 1997-12-08 2001-03-27 Smithkline Beechman Corp Sal de monoargininilo del acido(e)-3-(1-n-butil-5-(2-(2- carboxifenil)metoxi-4-clorofenil)-1h-pirazol-4-il)-2- ((5-metoxi-2,3-dihidrobenzofuran-5-il)metil)-prop-2-enoico
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen
US7087630B2 (en) * 2002-06-27 2006-08-08 Nitromed, Inc. Cyclooxygenase 2 selective inhibitors, compositions and methods of use
WO2006075955A1 (en) * 2005-01-13 2006-07-20 Astrazeneca Ab Pyrazolyl acylsulfonamide derivatives as endothelin converting enzyme inhibitors and useful in the treatment of chronic obstructive pulmonary disease
US7521435B2 (en) * 2005-02-18 2009-04-21 Pharma Diagnostics, N.V. Silicon containing compounds having selective COX-2 inhibitory activity and methods of making and using the same
US8012038B1 (en) 2008-12-11 2011-09-06 Taylor Made Golf Company, Inc. Golf club head
US10086240B1 (en) 2015-08-14 2018-10-02 Taylor Made Golf Company, Inc. Golf club head
EP3380970B1 (en) * 2015-11-24 2023-01-04 Sanford Burnham Prebys Medical Discovery Institute Novel azole derivatives as apelin receptor agonist
US10773135B1 (en) 2019-08-28 2020-09-15 Taylor Made Golf Company, Inc. Golf club head

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1937241A1 (de) * 1968-08-02 1970-02-19 Sumitomo Chemical Co 3,5-Dioxopyrazolidinderivate und Verfahren zu ihrer Herstellung
JPH01211582A (ja) * 1988-02-16 1989-08-24 Tanabe Seiyaku Co Ltd ベンゾジオキソール誘導体
EP0403158A3 (en) * 1989-06-14 1991-12-18 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
AU9137791A (en) * 1990-12-14 1992-07-08 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
FR2682379B1 (fr) * 1991-10-09 1994-02-11 Rhone Poulenc Agrochimie Nouveaux phenylpyrazoles fongicides.
WO1994022830A1 (en) * 1993-03-31 1994-10-13 Smithkline Beecham Corporation Chemical compounds
JP2847969B2 (ja) * 1993-08-18 1999-01-20 萬有製薬株式会社 エンドセリン拮抗活性を有する複素芳香環縮合シクロペンテン誘導体
IL111613A0 (en) * 1993-11-12 1995-01-24 Rhone Poulenc Rorer Ltd Substituted phenyl compounds, their preparation and pharmaceutical compositions containing them
EP0778833B1 (en) * 1994-09-02 2002-05-15 SmithKline Beecham Corporation Endothelin receptor antagonists

Also Published As

Publication number Publication date
HUP9902817A2 (hu) 1999-12-28
EA000952B1 (ru) 2000-08-28
CZ30498A3 (cs) 1998-07-15
WO1997004773A1 (en) 1997-02-13
ES2171697T3 (es) 2002-09-16
ATE341324T1 (de) 2006-10-15
DE69636597D1 (de) 2006-11-16
SK11398A3 (en) 1998-07-08
AU6646396A (en) 1997-02-26
EP0843551A4 (en) 1998-08-12
AP9801182A0 (en) 1998-01-31
NO980422D0 (no) 1998-01-30
CA2228296A1 (en) 1997-02-13
JPH11511133A (ja) 1999-09-28
HUP9902817A3 (en) 2001-03-28
US6353116B1 (en) 2002-03-05
DE69619116T2 (de) 2002-09-19
NO980422L (no) 1998-03-24
EP0841925A1 (en) 1998-05-20
DE69619116D1 (de) 2002-03-21
BR9609914A (pt) 1999-07-06
EP0843551B1 (en) 2002-02-06
TR199800152T1 (xx) 1998-05-21
SK282584B6 (sk) 2002-10-08
DE69636597T2 (de) 2007-08-16
US6096897A (en) 2000-08-01
US20020072614A1 (en) 2002-06-13
US5958968A (en) 1999-09-28
AU717172B2 (en) 2000-03-16
EP0841925A4 (en) 2001-10-17
AU6764596A (en) 1997-02-26
PL184272B1 (pl) 2002-09-30
US5969151A (en) 1999-10-19
OA10755A (en) 2002-12-13
NZ315846A (en) 1999-01-28
RO115802B1 (ro) 2000-06-30
CN1196680A (zh) 1998-10-21
JP2001517195A (ja) 2001-10-02
MX9800975A (es) 1998-04-30
ES2273350T3 (es) 2007-05-01
EP0843551A1 (en) 1998-05-27
HU220776B1 (hu) 2002-05-28
EP0841925B1 (en) 2006-10-04
US6482956B2 (en) 2002-11-19
EA199800185A1 (ru) 1998-10-29
KR19990036032A (ko) 1999-05-25
WO1997004772A1 (en) 1997-02-13
PL324745A1 (en) 1998-06-08
CA2228293A1 (en) 1997-02-13

Similar Documents

Publication Publication Date Title
IL114599A (en) Substituted pyrimidine compounds their preparation and pharmaceutical compositions containg them
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
MY117274A (en) Polycyclic amine compounds and their enantiomers,their method of preparation and pharmaceutical compositions in which they are present.
MX9800125A (es) Nuevas composiciones medicinales estables para generar aerosoles libres de gas propulsor.
MXPA02009773A (es) Derivados de indolin-2-ona y su uso como ligandos de receptores de ocitocina.
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
IL117091A (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation threreof
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
BG104916A (bg) Калцилитични съединения
MX9801890A (es) Nuevos compuestos antagonistas selectivos del receptor nk3 humano, procedimiento para su obtencion y composiciones farmaceuticas que los contienen.
NO944781L (no) 2,5-diokso-2,5-dihydro-1H-benz(b)azepiner som NMDA-reseptor-antagonister
HUP0001165A3 (en) Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists, pharmaceutical compositions containing them and process for producing them
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
BG102229A (bg) Антагонисти на ендотелинови рецептори
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
HUP0202433A3 (en) Substituted pyrrolidin-2,3,4-trion-3-oxime derivatives useful as nmda-receptor antagonists, process for producing them and pharmaceutical compositions containing them
AU4925200A (en) Oral composition containing perlite
IL128500A (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BG101849A (bg) Бициклични тахикининови антагонисти, тяхното приготовляване и използуване в фармацевтични състави
YU48200A (sh) Farmaceutski preparati
EP0778833A4 (en) ENDOTHELIN RECEPTOR ANTAGONISTS
AU1356299A (en) New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists
AU6263190A (en) Extracellular exopolymer, process for its preparation and pharmaceutical compositions containing the said exopolymer
MY133085A (en) New 2,3,3a,4,9,9a-hexahydro-8-hydroxy-1h-benz<f>indoles, processes for preparing them and their use as pharmaceutical compositions